Bloomberg Law
March 24, 2023, 3:23 PM

Tepezza Patient Seeks Single Proceeding for Eye Drug Litigation

Julie Steinberg
Julie Steinberg

Lawsuits alleging that Horizon Therapeutics USA Inc.'s eye drug Tepezza causes hearing loss and tinnitus should be combined and sent to a San Francisco courtroom, a New York woman told the US Judicial Panel on Multidistrict Litigation.

Tepezza was meant to treat thyroid eye disease, an inflammatory condition that can cause the eyes and eyelids to become red, swollen, and uncomfortable. Combining the lawsuits into a single proceeding will increase efficiency and fairness, given the common legal and factual questions, Kimberly Exton says in a filing.

  • The company aggressively marketed Tepezza while failing to warn that the infusion drug can ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.